Skip to content
Adopted text

Genetically modified oilseed rape MON 88302

TA-10-2025-0290 · P10_TA(2025)0290 · PE778.109

✦ In short · AI summary of this text, generated 4 Sept 2026

Written by a language model from the full text only; every figure comes from the text. The paragraph links open the paragraph a statement rests on — check the text itself before relying on it.

Parliament's resolution objects to the draft Commission decision renewing authorisation for genetically modified oilseed rape MON 88302, citing risks to health and environment. It calls on the Commission to withdraw the draft decision, not renew the authorisation, and reform the GMO approval process.

Key points

  1. Considers that the draft Commission implementing decision exceeds implementing powers under Regulation (EC) No 1829/2003.
  2. Finds the draft decision incompatible with Union law, as it conflicts with the aim of ensuring high protection of human, animal, and environmental health, and the precautionary principle.
  3. Calls on the Commission to withdraw its draft implementing decision.
  4. Calls on the Commission not to renew authorisation due to concerns about gene flow, environmental persistence, herbicide use, and insufficient long-term evidence, in line with the One Health approach.
  5. Calls on the Commission to submit a legislative proposal to reform the GMO decision-making procedure, responding to Parliament's objections and lack of qualified majority among Member States.
  6. Urges the Commission to consider EU obligations under international agreements like the Paris Climate Agreement, the UN Convention on Biological Diversity, and the UN Sustainable Development Goals.

Who is affected

  • The Commission, which is asked to withdraw the draft decision and not renew authorisation.
  • Bayer Agriculture B.V. and Bayer CropScience LP, applicants for renewal, whose authorisation would not be renewed.

Legal basis: Article 191 of the Treaty on the Functioning of the European Union